• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$64.85 $0.76 (1.19%)

REAL-TIME: Last trade at

Vertex Pharmaceuticals

NASDAQ:VRTX

7 Biotech Stocks to Add to Your Portfolio

Vertex Announces Webcast of its Presentations at Two Investor Conferences

Vertex Pharmaceuticals management to meet with JPMorgan

Vertex finds key support for cystic fibrosis drug in Europe

Vertex Pharmaceuticals receives CHMP positive opinion for KALYDECO

Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis

Upstart biotech lures Vertex founder out of retirement

Vertex falls after analyst expresses doubt about cystic fibrosis drug

Perception, Opportunity in Volatility - Research & Analysis on Vertex Pharmaceuticals Incorporated and Huntington Bancshares Incorporated

Perception, Opportunity in Volatility - Research & Analysis on Vertex Pharmaceuticals Incorporated and Huntington Bancshares Incorporated

Vertex Appoints David Altshuler, M.D., Ph.D., to its Board of Directors

Cramer's 'Mad Money' Recap: Put Some Meat Into Your Holdings With Hormel

Chelsea: A Short-Term Buying Opportunity

The Street: A List of the Top Drug Studies Left in 2012

How CDC's hep.-C testing advice is already benefiting drugmakers

Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

22 Biopharma Stocks With Breakout Potential in 2012

BofA/Merrill's senior biotech analyst holds a conference call

The Definitive Biotech ETF Guide (IBB, XBI, FBT)

Hepatitis C tests recommended for baby boomers

U.S. Suggests All Baby Boomers Should Get Tested for Hepatitis C

Bionest Publishes Landmark Article on Quantitative Financial Analysis of Personalized Medicine Strategies

Bionest Publishes Landmark Article on Quantitative Financial Analysis of Personalized Medicine Strategies

Biotech Sector Avoids Nasty Correction And Hits New Highs

Biotech Stock Live Chat: ASCO & Obesity

JP Morgan's biotechnology analyst holds a conference call

The Crohn’s and Colitis Foundation of Canada and Vertex Announce Collaboration to Fund Research in Inflammatory Bowel Disease

Redefining The Meaning Of 'Creating Shareholder Value' In Biotech

Vertex Forecast Promising

Stocks with implied volatility below IV index mean; SUN VRTX

Medmeme, LLC. Identifies Competition-Changing Trends In Virology Treatments

Vertex Pharma continues to rise on upgrade

Highs & Lows: Eldorado Gold, Symantec, and Vertex Pharmaceuticals

Highs & Lows: Eldorado Gold, Symantec, and Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, Medivation Among Stocks Hitting 52-Week Highs Monday

Cramer's Six in 60: TDC, NOK & More

A Health Care Fortnight for the Record Books

JP Morgan hosts an analyst Biotechnology/Industry conference call

Top Analyst Upgrades & Downgrades

Vertex Pharmaceuticals upgraded to Overweight from Neutral at JPMorgan

See More Articles...